Browse > Article
http://dx.doi.org/10.14348/molcells.2018.0028

Role of Dehydrocorybulbine in Neuropathic Pain After Spinal Cord Injury Mediated by P2X4 Receptor  

Wang, Zhongwei (Department of Orthopaedics, The First Affiliated Hospital of Zhengzhou University)
Mei, Wei (Department of Spine Surgery, Zhengzhou Orthopaedic Hospital)
Wang, Qingde (Department of Spine Surgery, Zhengzhou Orthopaedic Hospital)
Guo, Rundong (Department of Spine Surgery, Zhengzhou Orthopaedic Hospital)
Liu, Peilin (Department of Spine Surgery, Zhengzhou Orthopaedic Hospital)
Wang, Yuqiang (Department of Orthopaedics, The First Affiliated Hospital of Zhengzhou University)
Zhang, Zijuan (Experimental Teaching Center, School of Basic Medical Science, Henan University of Chinese Medicine)
Wang, Limin (Department of Orthopaedics, The First Affiliated Hospital of Zhengzhou University)
Publication Information
Molecules and Cells / v.42, no.2, 2019 , pp. 143-150 More about this Journal
Abstract
Chronic neuropathic pain is one of the primary causes of disability subsequent to spinal cord injury. Patients experiencing neuropathic pain after spinal cord injury suffer from poor quality of life, so complementary therapy is seriously needed. Dehydrocorybulbine is an alkaloid extracted from Corydalis yanhusuo. It effectively alleviates neuropathic pain. In the present study, we explored the effect of dehydrocorybulbine on neuropathic pain after spinal cord injury and delineated its possible mechanism. Experiments were performed in rats to evaluate the contribution of dehydrocorybulbine to P2X4 signaling in the modulation of pain-related behaviors and the levels of pronociceptive interleukins and proteins after spinal cord injury. In a rat contusion injury model, we confirmed that chronic neuropathic pain is present on day 7 after spinal cord injury and P2X4R expression is exacerbated after spinal cord injury. We also found that administration of dehydrocorybulbine by tail vein injection relieved pain behaviors in rat contusion injury models without affecting motor functions. The elevation in the levels of pronociceptive interleukins ($IL-1{\beta}$, IL-18, MMP-9) after spinal cord injury was mitigated by dehydrocorybulbine. Dehydrocorybulbine significantly mitigated the upregulation of P2X4 receptor and reduced ATP-evoked intracellular $Ca^{2+}$ concentration. Both P2XR and dopamine receptor2 agonists antagonized dehydrocorybulbine's antinociceptive effects. In conclusion, we propose that dehydrocorybulbine produces antinociceptive effects in spinal cord injury models by inhibiting P2X4R.
Keywords
dehydrocorybulbine; P2X4; Pain; Spinal cord injury;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Ma, Z.Z., Xu, W., Jensen, N.H., Roth, B.L., Liu-Chen, L.Y., and Lee, D.Y.W. (2008). Isoquinoline alkaloids isolated from Corydalis yanhusuo and their binding affinities at the dopamine D1 receptor. Molecules 13, 2303-2312.   DOI
2 Pain, S. (2016). Painful progress. Nature 535, S18-S19.   DOI
3 Rubini, P., Engelhardt, J., Wirkner, K., and Illes, P. (2008). Modulation by D1 and D2 dopamine receptors of ATP-induced release of intracellular $Ca^{2+}$ in cultured rat striatal neurons. Neurochem. Int. 52, 113-118.   DOI
4 Tsuda, M., Shigemoto-Mogami, Y., Koizumi, S., Mizokoshi, A., Kohsaka, S., Salter, M.W., and Inoue, K. (2003). P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury. Nature 424, 778-783.   DOI
5 Ulmann, L., Hatcher, J.P., Hughes, J.P., Chaumont, S., Green, P.J., Conquet, F., Buell, G.N., Reeve, A.J., Chessell, I.P., and Rassendren, F. (2008). Up-regulation of P2X4 receptors in spinal microglia after peripheral nerve injury mediates BDNF release and neuropathic pain. J. Neurosci. 28, 11263-11268.   DOI
6 van Gorp, S., Kessels, A.G., Joosten, E.A., van Kleef, M., and Patijn, J. (2015). Pain prevalence and its determinants after spinal cord injury: a systematic review. Eur. J. Pain 19, 5-14.   DOI
7 Wang, L., Zhang, Y., Wang, Z., Gong, N., Kweon, T.D., Vo, B., Wang, C., Zhang, X., Chung, J.Y., Alachkar, A., et al. (2016). The antinociceptive properties of the corydalis yanhusuo extract. PLoS ONE 11, e0162875.   DOI
8 Zhang, M.Y., Liu, Y.P., Zhang, L.Y., Yue, D.M., Qi, D.Y., Liu, G.J., and Liu, S. (2015). Levo-tetrahydropalmatine attenuates bone cancer pain by inhibiting microglial cells activation. Mediators Inflamm. 2015, 752512-752519.
9 Yuan, C.S., Mehendale, S.R., Wang, C.Z., Aung, H.H., Jiang, T., Guan, X., and Shoyama, Y. (2004). Effects of Corydalis yanhusuo and Angelicae dahuricae on cold pressor-induced pain in humans: a controlled trial. J. Clin. Pharmacol. 44, 1323-1327.   DOI
10 Yan, J., Fu, Z., Zhang, L., and Li C. (2018). Orai1 is involved in leptinsensitive cell maturation in mouse dendritic cells. Biochem. Biophys. Res. Commun. 503, 1747-1753.   DOI
11 Beattie, M.S., Hermann, G.E., Rogers, R.C., and Bresnahan, J.C. (2002). Cell death in models of spinal cord injury. Prog. Brain Res. 137, 37-47.   DOI
12 Zhang, Y., Wang, C., Wang, L., Parks, G.S., Zhang, X., Guo, Z., Ke, Y., Li, K.-W., Kim, M.K., Vo, B., et al. (2014). A novel analgesic isolated from a traditional Chinese medicine. Curr. Biol. 24, 117-123.   DOI
13 Zhou, H.H., Wu, D.L., Gao, L.Y., Fang, Y., and Ge, W.-H. (2016). L-Tetrahydropalmatine alleviates mechanical hyperalgesia in models of chronic inflammatory and neuropathic pain in mice. Neuroreport 27, 476-480.   DOI
14 Smith, R.G., Alexianu, M.E., Crawford, G., Nyormoi, O., Stefani, E., and Appel, S.H. (1994). Cytotoxicity of immunoglobulins from amyotrophic lateral sclerosis patients on a hybrid motoneuron cell line. Proc. Natl. Acad. Sci. USA 91, 3393-3397.   DOI
15 Lukovic, D., Moreno-Manzano, V., Lopez-Mocholi, E., Rodriguez-Jimenez, F.J., Jendelova, P., Sykova, E., Oria, M., Stojkovic, M., and Erceg, S. (2015). Complete rat spinal cord transection as a faithful model of spinal cord injury for translational cell transplantation. Sci Rep. 5, 9640.   DOI
16 Pelissier, T., Laurido, C., Hernandez, A., Constandil, L., and Eschalier, A. (2006). Biphasic effect of apomorphine on rat nociception and effect of dopamine D2 receptor antagonists. Eur. J. Pharmacol. 546, 40-47.   DOI
17 De, Rivero Vaccari J.P., Bastien, D., Yurcisin, G., Pineau, I., Dietrich, W.D., De Koninck, Y., Keane, R.W., and Lacroix, S. (2012). P2X4 receptors influence inflammasome activation after spinal cord injury. J. Neurosci. 32, 3058-3066.   DOI
18 Sakaki, H., Fujiwaki, T., Tsukimoto, M., Kawano, A., Harada, H., and Kojima, S. (2013). P2X4 receptor regulates P2X7 receptordependent IL-$1{\beta}$ and IL-18 release in mouse bone marrow-derived dendritic cells. Biochem. Biophys. Res. Commun. 432, 406-411.   DOI
19 Burnstock, G. (2006). Purinergic P2 receptors as targets for novel analgesics. Pharmacol. Ther. 110, 433-454.   DOI
20 Almeida-Santos, A.F., Ferreira, R.C.M., Duarte, I.D., Aguiar, D.C., Romero, T.R.L., and Moreira, F.A. (2015). The antipsychotic aripiprazole induces antinociceptive effects: Possible role of peripheral dopamine D2 and serotonin 5-HT1A receptors. Eur. J. Pharmacol. 765, 300-306.   DOI
21 Cao, F.L., Shang, G.W., Wang, Y., Yang, F., Li, C.L., and Chen, J. (2011). Antinociceptive effects of intragastric DLtetrahydropalmatine on visceral and somatic persistent nociception and pain hypersensitivity in rats. Pharmacol. Biochem. Behav. 100, 199-204.   DOI
22 Chu, H., Jin, G., Friedman, E., and Zhen, X. (2008). Recent development in studies of tetrahydroprotoberberines: mechanism in antinociception and drug addiction. Cell. Mol. Neurobiol. 28, 491-499.   DOI
23 Cobacho, N., la Calle, de, J.L., and Paino, C.L. (2014). Dopaminergic modulation of neuropathic pain: analgesia in rats by a D2-type receptor agonist. Brain Res. Bull. 106, 62-71.   DOI
24 David, S., and Kroner, A. (2011). Repertoire of microglial and macrophage responses after spinal cord injury. Nat. Rev. Neurosci. 12, 388-399.   DOI
25 Ferrari, D., Chiozzi, P., Falzoni, S., Hanau, S., and Di Virgilio, F. (1997). Purinergic modulation of interleukin-1 beta release from microglial cells stimulated with bacterial endotoxin. J. Exp. Med. 185, 579-582.   DOI
26 Jurga, A.M., Piotrowska, A., Makuch, W., Przewlocka, B., and Mika, J. (2017). Blockade of P2X4 Receptors Inhibits Neuropathic Pain-Related Behavior by Preventing MMP-9 Activation and, Consequently, Pronociceptive Interleukin Release in a Rat Model. Front. Pharmacol. 8, 48.
27 Zhang, D., Xuan, J., Zheng, B.B., Zhou, Y.L., Lin, Y., Wu, Y.S., Zhou, Y.F., Huang, Y.X., Wang, Q., Shen, L.Y., et al. (2017). Metformin improves functional recovery after spinal cord injury via autophagy flux stimulation. Mol. Neurobiol. 54, 1-15.   DOI
28 Sharif-Alhoseini, M., Khormali, M., Rezaei, M., Safdarian, M., Hajighadery, A., Khalatbari, M.M., Safdarian, M., Meknatkhah, S., Rezvan, M., Chalangari, M., et al. (2017). Animal models of spinal cord injury: a systematic review. Spinal Cord. 55, 714-721.   DOI
29 Hagelberg, N., Martikainen, I.K., Mansikka, H., Hinkka, S., Någren, K., Hietala, J., Scheinin, H., and Pertovaara, A. (2002). Dopamine D2 receptor binding in the human brain is associated with the response to painful stimulation and pain modulatory capacity. Pain 99, 273-279.   DOI
30 He, Y., Taylor, N., Fourgeaud, L., and Bhattacharya, A. (2017). The role of microglial P2X7: modulation of cell death and cytokine release. J. Neuroinflammation 14, 135.   DOI
31 Kang, D.W., Moon, J.Y., Choi, J.G., Kang, S.Y., Ryu, Y., Park, J.B., Lee, J.H., and Kim, H.W. (2016). Antinociceptive profile of levotetrahydropalmatine in acute and chronic pain mice models: role of spinal sigma-1 receptor. Sci. Rep. 6, 37850.   DOI
32 Lee, Y.L., Sagare, A.P., Lee, C.Y., Feng, H.T., Ko, Y.C., Shaw, J.F., and Tsay, H.S. (2001). Formation of protoberberine-type alkaloids by the tubers of somatic embryo-derived plants of Corydalis yanhusuo. Planta Med. 67, 839-842.   DOI
33 Lefevre, Y., Amadio, A., Vincent, P., Descheemaeker, A., Oliet, S.H.R., Dallel, R., and Voisin, D.L. (2015). Neuropathic pain depends upon Dserine co-activation of spinal NMDA receptors in rats. Neurosci. Lett. 603, 42-47.   DOI